$ABVC News Article - ABVC BioPharma Entered Into a Term Sheet to License Global Rights of CNS Drugs with the Indications of MDD and ADHD to AiBtl BioPharma at the Valuation of $667 Million https://marketwirenews.com/news-releases/abvc...82160.html
(0)
(0)
American BriVision (Holding) Corporation (ABVC) Stock Research Links